We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

3661:TWSEAlchip Technologies Ltd. Analysis

Data as of 2026-09-02 - not real-time

NT$4,200.00

Latest Price

9/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind Alchip Technologies, Limited is bullish at TWD 4,200.00, with short-term averages leading the long-term ones. Over a rolling month the price has gained 17.0%. Momentum indicators put RSI at 60.0 (approaching overbought) with MACD reading bullish. Price has been bracketed by support at TWD 3,580.00 and resistance at TWD 4,530.00.
Multiples put this in overvalued territory: 61.0 times earnings against the sector's 35.3. Consensus targets land 36.3% above where the shares trade now. Revenue is contracting at 16.5% on a 25.4% profit margin. The 0.76% dividend yield looks covered by current payout levels.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 74.5%, a beta of 1.53 and a maximum drawdown of 48.2%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.

Top Market Events

Taipei, Taiwan, June 25, 2026 GLOBE NEWSWIRE -- Alchip Technologies, Ltd.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 3674.80
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 61.0 versus sector average of 35.3
  • Trading above the 200-day average of 3674.80

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 61.0 versus sector average of 35.3
  • Analyst targets imply +36.3% versus the current price
  • Profit margin of 25.4% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth-16.50%
Profit Margin25.42%
P/E Ratio61.0
ROE12.31%
ROA4.88%
Debt/Equity0.48
P/B Ratio6.0
Op. Cash FlowNT$-361985984
Free Cash FlowNT$-2559589120
Industry P/E35.3

Technical Analysis

TrendBullish
RSI60.0
SupportNT$3,580.00
ResistanceNT$4,530.00
MA 20NT$3,924.25
MA 50NT$3,823.20
MA 200NT$3,674.80
MACDBullish
VolumeDecreasing
Fear & Greed Index92.68

Valuation

Target PriceNT$5,726.56
Upside/Downside36.35%
GradeOvervalued
TypeGrowth
Dividend Yield0.76%

Risk Assessment

Beta1.53
Volatility74.45%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.